Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Julia Lenore Marcus, Ph.D.

Concepts

This page shows the publications Julia Marcus has written about Female.
Connection Strength

0.336
  1. Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S. AIDS Behav. 2022 Jul; 26(7):2212-2223.
    View in: PubMed
    Score: 0.015
  2. Brief Report: HIV Pre-exposure Prophylaxis Prescribing in an Urban Safety-Net Health System. J Acquir Immune Defic Syndr. 2021 11 01; 88(3):e17-e21.
    View in: PubMed
    Score: 0.015
  3. Nondaily Use of HIV Preexposure Prophylaxis in a Large Online Survey of Primarily Men Who Have Sex With Men in the United States. J Acquir Immune Defic Syndr. 2020 06 01; 84(2):182-188.
    View in: PubMed
    Score: 0.014
  4. Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016. JAMA Netw Open. 2020 06 01; 3(6):e207954.
    View in: PubMed
    Score: 0.014
  5. Use of Intrauterine Devices and Risk of Human Immunodeficiency Virus Acquisition Among Insured Women in the United States. Clin Infect Dis. 2020 05 06; 70(10):2221-2223.
    View in: PubMed
    Score: 0.013
  6. Tenofovir Alafenamide for HIV Preexposure Prophylaxis: What Can We DISCOVER About Its True Value? Ann Intern Med. 2020 02 18; 172(4):281-282.
    View in: PubMed
    Score: 0.013
  7. Use of electronic health record data and machine learning to identify candidates for HIV pre-exposure prophylaxis: a modelling study. Lancet HIV. 2019 10; 6(10):e688-e695.
    View in: PubMed
    Score: 0.013
  8. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system. Int J STD AIDS. 2019 06; 30(7):689-695.
    View in: PubMed
    Score: 0.013
  9. Risk Compensation and Clinical Decision Making - The Case of HIV Preexposure Prophylaxis. N Engl J Med. 2019 Feb 07; 380(6):510-512.
    View in: PubMed
    Score: 0.012
  10. Low-Intensity Outreach to Increase Uptake of HIV Preexposure Prophylaxis Among Patients with Sexually Transmitted Infections. AIDS Behav. 2019 Feb; 23(2):544-547.
    View in: PubMed
    Score: 0.012
  11. Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California. AIDS Care. 2019 05; 31(5):536-544.
    View in: PubMed
    Score: 0.012
  12. Recurrence after hospitalization for acute coronary syndrome among HIV-infected and HIV-uninfected individuals. HIV Med. 2019 01; 20(1):19-26.
    View in: PubMed
    Score: 0.012
  13. Progress and pitfalls in measuring HIV preexposure prophylaxis coverage in the United States. Ann Epidemiol. 2018 12; 28(12):830-832.
    View in: PubMed
    Score: 0.012
  14. HIV Preexposure Prophylaxis as a Gateway to Primary Care. Am J Public Health. 2018 10; 108(10):1418-1420.
    View in: PubMed
    Score: 0.012
  15. No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients. Clin Gastroenterol Hepatol. 2018 06; 16(6):927-935.
    View in: PubMed
    Score: 0.012
  16. Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals. AIDS. 2017 04 24; 31(7):989-993.
    View in: PubMed
    Score: 0.011
  17. Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation. J Acquir Immune Defic Syndr. 2016 Dec 15; 73(5):540-546.
    View in: PubMed
    Score: 0.011
  18. Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System. AIDS Patient Care STDS. 2016 10; 30(10):463-470.
    View in: PubMed
    Score: 0.011
  19. Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care. J Acquir Immune Defic Syndr. 2016 09 01; 73(1):39-46.
    View in: PubMed
    Score: 0.010
  20. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status. AIDS Patient Care STDS. 2015 Jul; 29(7):370-8.
    View in: PubMed
    Score: 0.010
  21. Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1167-73.
    View in: PubMed
    Score: 0.009
  22. HIV infection and incidence of ischemic stroke. AIDS. 2014 Aug 24; 28(13):1911-9.
    View in: PubMed
    Score: 0.009
  23. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One. 2013; 8(12):e81997.
    View in: PubMed
    Score: 0.009
  24. Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the female oropharynx to the male urethra. Sex Transm Dis. 2011 May; 38(5):372-3.
    View in: PubMed
    Score: 0.007
  25. Evidence of underreporting of adverse childhood experiences, San Francisco municipal STD clinic, 2007. Sex Transm Dis. 2009 Jul; 36(7):422-4.
    View in: PubMed
    Score: 0.006
  26. Updated outcomes of partner notification for human immunodeficiency virus, San Francisco, 2004-2008. AIDS. 2009 May 15; 23(8):1024-6.
    View in: PubMed
    Score: 0.006
  27. Cannabis Use and Patient-Centered Care During Pregnancy and Post Partum Among People Living With HIV. JAMA Netw Open. 2021 12 01; 4(12):e2137588.
    View in: PubMed
    Score: 0.004
  28. Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals. Cancer Epidemiol Biomarkers Prev. 2021 12; 30(12):2188-2196.
    View in: PubMed
    Score: 0.004
  29. Characterization of HIV Preexposure Prophylaxis Use Behaviors and HIV Incidence Among US Adults in an Integrated Health Care System. JAMA Netw Open. 2021 08 02; 4(8):e2122692.
    View in: PubMed
    Score: 0.004
  30. Secular Trends in Breast Cancer Risk Among Women With HIV Initiating ART in North America. J Acquir Immune Defic Syndr. 2021 05 01; 87(1):663-670.
    View in: PubMed
    Score: 0.004
  31. Associations Among HIV Risk Perception, Sexual Health Efficacy, and Intent to Use PrEP Among Women: An Application of the Risk Perception Attitude Framework. AIDS Educ Prev. 2020 10; 32(5):392-402.
    View in: PubMed
    Score: 0.003
  32. Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV. Sex Transm Infect. 2020 05; 96(3):184-188.
    View in: PubMed
    Score: 0.003
  33. Using HIV Risk Prediction Tools to Identify Candidates for Pre-Exposure Prophylaxis: Perspectives from Patients and Primary Care Providers. AIDS Patient Care STDS. 2019 08; 33(8):372-378.
    View in: PubMed
    Score: 0.003
  34. Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care. J Int AIDS Soc. 2019 02; 22(2):e25250.
    View in: PubMed
    Score: 0.003
  35. Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population. Clin Infect Dis. 2019 01 07; 68(2):213-221.
    View in: PubMed
    Score: 0.003
  36. No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting. Clin Infect Dis. 2015 Nov 15; 61(10):1601-3.
    View in: PubMed
    Score: 0.002
  37. Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care. Clin Infect Dis. 2015 Apr 15; 60(8):1278-80.
    View in: PubMed
    Score: 0.002
  38. Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection. J Acquir Immune Defic Syndr. 2014 Aug 15; 66(5):530-7.
    View in: PubMed
    Score: 0.002
  39. Using HIV testing history to measure the success of HIV partner services. Sex Transm Dis. 2013 May; 40(5):419-21.
    View in: PubMed
    Score: 0.002
  40. Reduction in unnecessary Chlamydia screening among older women at title X-funded family planning sites following a structural intervention--San Francisco, 2009. Sex Transm Dis. 2011 Feb; 38(2):127-9.
    View in: PubMed
    Score: 0.002
  41. Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007. BMC Public Health. 2009 Jan 14; 9:17.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.